Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	IPO [Member]	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive income (loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2019	$ (8,445)		$ 0	$ 1		$ 18,273		$ (26,719)
Beginning balance (in shares) at Dec. 31, 2019			0	63,633,981	0
Shares issued during the period for vested restricted stock awards, Shares				3,255,049
Repurchase of treasury stock, held in treasury				(9,896,666)	9,896,666
Issuance of common stock, value	30,000					30,000
Issuance of common stock (in shares)				9,162,976
Stock-based compensation	1,823					1,823
Net Income (loss)	(15,924)							(15,924)
Other comprehensive income (loss)	(3)						(3)
Ending balance at Dec. 31, 2020	7,451		$ 0	$ 1	$ 0	50,096	(3)	(42,643)
Ending balance (in shares) at Dec. 31, 2020			0	66,155,340	9,896,666
Shares issued during the period for vested restricted stock awards, Shares				9,107,121
Repurchase of treasury stock, held in treasury				(865,900)	865,900
Issuance of common stock upon exercise of stock options	317			$ 1		316
Issuance of common stock upon exercise of stock options (in shares)				2,838,464
Repurchase and retirement of common stock held by related parties	(54,155)			$ (1)		(54,154)
Repurchase and retirement of common stock held by related parties (shares)				(4,455,384)
Impact of Stock Split				$ 6		(6)
Deferred offering costs	(7,088)					(7,088)
Issuance of common stock, value	241,155			$ 2		241,153
Issuance of common stock (in shares)				19,840,000
Stock-based compensation	61,765					61,765
Net Income (loss)	(106,589)							(106,589)
Other comprehensive income (loss)	10						10
Ending balance at Dec. 31, 2021	142,866		$ 0	$ 9		292,082	7	(149,232)
Ending balance (in shares) at Dec. 31, 2021			0	92,619,641	10,762,566
Shares issued during the period for vested restricted stock awards, Value	4,062			$ 1		4,061
Shares issued during the period for vested restricted stock awards, Shares				8,096,868
Issuance of common stock upon exercise of stock options	$ 903			$ 1		902
Issuance of common stock upon exercise of stock options (in shares)	3,316,079			3,316,079
Shares issued for HX Tracker acquisition, Shares				1,000,000
Shares issued for HX Tracker acquisition, Amount	$ 4,370					4,370
Issuance of common stock (in shares)		4,455,384
Stock-based compensation	13,930					13,930
Net Income (loss)	(99,613)							(99,613)
Other comprehensive income (loss)	(68)						(68)
Ending balance at Dec. 31, 2022	$ 66,450		$ 0	$ 11	$ 0	$ 315,345	$ (61)	$ (248,845)
Ending balance (in shares) at Dec. 31, 2022			0	105,032,588	10,762,566